Key Financial Highlights (₹ in Crores)
| Particulars | Q3 FY25 | Q2 FY25 | Q3 FY24 | 9M FY25 | 9M FY24 | FY24 (Audited) |
|---|---|---|---|---|---|---|
| Revenue from Operations | 606.20 | 518.56 | 500.12 | 1,648.44 | 1,463.06 | 2,065.01 |
| Total Revenue | 616.68 | 529.72 | 512.04 | 1,680.34 | 1,506.39 | 2,120.86 |
| EBITDA | 157.79 | 118.51 | 87.59 | 387.24 | 332.56 | 461.13 |
| EBITDA Margin | 25.8% | 22.4% | 17.1% | 23.1% | 22.1% | 21.7% |
| Net Profit | 83.60 | 58.82 | 78.02 | 193.62 | 200.13 | 270.51 |
| EPS (₹, Basic) | 16.86 | 11.86 | 15.74 | 39.05 | 40.37 | 54.57 |
Performance Analysis
- Revenue Growth:
- Navin Fluorine reported a YoY revenue growth of 21.2%, with Q3 FY25 revenue at ₹606.2 crore, up from ₹500.1 crore in Q3 FY24.
- 9M FY25 revenue stood at ₹1,648.4 crore, reflecting a 12.7% YoY increase.
- Profitability & Margins:
- The company’s EBITDA margin expanded to 25.8% in Q3 FY25, compared to 17.1% in Q3 FY24, highlighting improved operational efficiency.
- Net profit rose 7.1% YoY to ₹83.6 crore, despite rising finance costs and depreciation expenses.
- Exceptional Gains & Taxation:
- Unlike Q3 FY24, which included a one-time exceptional gain of ₹52.13 crore from land sales, Q3 FY25 results were purely operational.
- Tax expenses for the quarter stood at ₹24.42 crore, compared to ₹19.13 crore in Q3 FY24.
Segment-Wise Performance
- Specialty Chemicals & CRAMS: The company’s focus on high-margin specialty chemicals and its contract research & manufacturing (CRAMS) division has been a major growth driver.
- Fluorochemicals Business: Revenue from fluorine-based products continues to contribute significantly, benefiting from strong demand in global pharma and agrochemical sectors.
Dividend & Corporate Announcements
- Interim Dividend: Navin Fluorine declared an interim dividend of ₹5 per share (250%), amounting to a total payout of ₹24.79 crore for FY25.
- Subsidiary Performance: The company’s consolidated results include contributions from its subsidiaries, including Manchester Organics (UK), NFIL USA Inc., and Navin Fluorine Advanced Sciences Ltd.
Management Commentary
Niti Kulkarni, Managing Director, stated:"Navin Fluorine continues to deliver robust revenue growth, driven by our focus on specialty fluorochemicals and CRAMS. Our strong EBITDA margin expansion reflects operational efficiencies and improved product mix. With increasing global demand for high-value fluorine-based intermediates, we remain optimistic about sustained growth."
Outlook & Future Growth Strategy
- Capacity Expansion: The company is expanding manufacturing capacity to cater to rising demand in pharmaceuticals and electronics applications.
- R&D Investments: Strengthening research & development for new-age fluorine derivatives and high-performance materials.
- Global Expansion: Growing international business through strategic partnerships and acquisitions.